Management of Dilated Cardiomyopathy in a Labrador

Khushi Sharma; Satish Kumar  K; Manaswini, M.,  Ashwini, S., Zeenath Fathima and Rachana, T.

doi:10.56093/ijvm.v45i1.167943

Authors

Khushi Sharma Department of Veterinary Medicine, College of Veterinary Science, Rajendranagar Hyderabad
Satish Kumar K Department of Veterinary Medicine, College of Veterinary Science, Rajendranagar Hyderabad
Manaswini, M., Ashwini, S., Zeenath Fathima and Rachana, T. Department of Veterinary Medicine, College of Veterinary Science, Rajendranagar PVNRTVU, Hyderabad-30

https://doi.org/10.56093/ijvm.v45i1.167943

Keywords:

Dilated Cardiomyopathy, Labrador, diagnostic imaging, triple therapy

Abstract

Dilated cardiomyopathy is the most common form of cardiomyopathy in canines which is characterized by progressive ventricular dilation and loss of myocardial contractility. Four year old, male Labrador was presented with complaint of tachypnea, activity intolerance, inability to walk and inappetence for a period of 15 days to Veterinary Clinical Complex, CVSc., Rajendranagar, Hyderabad. ECG showed deep Q wave and elevated R-wave with VPCs which were also confirmed on 24 hour Holter. Elevated urea, uric acid and SDMA levels were noticed. Thoracic radiograph and echocardiography revealed biventricular dilation, globoid appearance of heart, systolic dysfunction with reduced ejection indices, thus diagnosing the case as DCM. The dog was treated with benazepril pimobendan and furosemide and there was significant clinical improvement after one month of therapy.

Downloads

Download data is not yet available.

References

Calvert, C. A., Jacobs, G. J., & Pickus, C. W. 1997. Occult dilated cardiomyopathy in Doberman Pinschers: Prevalence, incidence, and implications. J. Am. Vet. Med. Assoc., 210(4): 505–511.

Freeman, L. M. and Rush, J. E. 2022. Dilated cardiomyopathy in dogs: Etiology, diagnosis, and treatment. J. Vet. Cardiol., 40: 1–15.

Freid, K., Daminet, S., Smets, P. and Chetboul, V. 2021. Incidence of canine dilated cardiomyopathy, breed and age distributions, and impact on lifespan. J. Vet. Cardiol., 35: 1–10.

Keene, B. W., Atkins, C. E., Bonagura, J. D., Fox, P. R., Häggström, J., Fuentes, V. L. and Stepien, R. L. 2019. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. J. Vet. Internal Med., 33(3): 1127–1140.

Porciello, F., Guglielmini, C., & Baron Toaldo, M. (2022). Angiotensin receptor-neprilysin inhibitor (ARNi) in veterinary medicine: A new therapeutic option for canine heart failure? Veterinary Sciences, 9(5), 251.

Tidholm, A., & Häggström, J. 2023. Epidemiology and clinical features of canine dilated cardiomyopathy. Vet. Rec., 192(4): 123–129.